| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.39M | 2.20M | 2.55M | 7.97M | 9.17M | 2.23M |
| Gross Profit | 729.95K | 1.16M | 372.63K | 967.76K | 1.63M | 255.74K |
| EBITDA | -9.43M | -16.72M | -22.29M | -9.48M | -2.70M | -4.60M |
| Net Income | -18.30M | -19.42M | -23.51M | -10.53M | -4.70M | -5.76M |
Balance Sheet | ||||||
| Total Assets | 13.81M | 13.70M | 29.62M | 49.62M | 50.56M | 29.70M |
| Cash, Cash Equivalents and Short-Term Investments | 228.43K | 306.93K | 262.02K | 1.69M | 6.45M | 6.39M |
| Total Debt | 6.94M | 6.63M | 5.55M | 6.23M | 257.71K | 1.21M |
| Total Liabilities | 9.22M | 8.69M | 8.40M | 12.49M | 7.18M | 4.40M |
| Stockholders Equity | 6.93M | 7.43M | 23.52M | 39.39M | 45.76M | 27.52M |
Cash Flow | ||||||
| Free Cash Flow | -4.88M | -3.90M | -5.43M | -11.00M | -8.54M | -3.71M |
| Operating Cash Flow | -4.58M | -3.90M | -5.41M | -10.34M | -7.54M | -3.54M |
| Investing Cash Flow | 2.27M | 2.66M | 158.85K | -4.34M | -8.88M | -1.52M |
| Financing Cash Flow | 1.89M | 1.39M | 3.68M | 9.93M | 16.60M | 10.73M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
51 Neutral | £130.06M | -5.21 | -86.37% | ― | 732.03% | 12.60% | |
49 Neutral | £14.49M | -36.25 | -20.52% | ― | ― | ― | |
47 Neutral | £27.61M | -1.10 | -113.32% | ― | ― | ― | |
45 Neutral | £118.02M | -4.61 | -32.53% | ― | -58.85% | 55.03% | |
41 Neutral | £19.45M | -3.42 | -87.07% | ― | 3.87% | -160.00% | |
38 Underperform | £524.18K | -0.01 | -126.45% | ― | -64.78% | 59.65% |
EQTEC has secured a further extension of the maturity date on its £0.7 million convertible loan to 28 February 2026 and has drawn down an additional £75,000 from its existing convertible loan facility as it continues negotiations with lenders and a major shareholder over a broader funding package. The cash-conservation measures and new drawdown are expected to extend the company’s cash runway to the end of February 2026, but EQTEC cautions there is no certainty that a comprehensive funding solution will be agreed, underscoring ongoing short-term working capital pressures and continued reliance on creditor support.
The most recent analyst rating on (GB:EQT) stock is a Sell with a £0.07 price target. To see the full list of analyst forecasts on EQTEC plc stock, see the GB:EQT Stock Forecast page.
EQTEC plc announced the conversion of a £100,000 principal amount into 133,689,839 new ordinary shares under its facility with Global Investment Strategy UK Limited. These shares will be admitted to trading on AIM, increasing the total number of shares in issue to 928,681,342. This move reflects EQTEC’s ongoing efforts to strengthen its financial position and enhance its market presence in the clean energy sector.
The most recent analyst rating on (GB:EQT) stock is a Sell with a £0.07 price target. To see the full list of analyst forecasts on EQTEC plc stock, see the GB:EQT Stock Forecast page.
EQTEC plc announced the conversion of £75,000 into 116,099,071 new ordinary shares as part of a facility with Global Investment Strategy UK Limited. The new shares will be admitted to trading on AIM, increasing the total ordinary shares in issue to 794,991,503. This move reflects EQTEC’s ongoing efforts to strengthen its financial position and enhance its market presence in the sustainable energy sector.
The most recent analyst rating on (GB:EQT) stock is a Sell with a £0.07 price target. To see the full list of analyst forecasts on EQTEC plc stock, see the GB:EQT Stock Forecast page.
EQTEC plc has announced an extension of its collaboration with GRDF, bolstered by additional private funding to advance its methanation projects in France. The company secured further funding for the Green Gas Provence project in Istres and won a competitive R&D tender for a methanation system at the University of Lorraine. This funding supports EQTEC’s efforts to demonstrate the conversion of high-purity syngas into renewable methane, with a major utility expressing interest in the project’s outcomes. These developments highlight EQTEC’s progress in the clean-tech sector despite challenging market conditions.
The most recent analyst rating on (GB:EQT) stock is a Sell with a £0.10 price target. To see the full list of analyst forecasts on EQTEC plc stock, see the GB:EQT Stock Forecast page.
EQTEC plc announced a corporate and funding update, highlighting its challenging trading and funding environment due to broader market conditions in the clean energy sector. The company has a total corporate debt of approximately £6.1 million and is actively seeking additional funding to meet its short-term obligations. A preliminary agreement with Rebel Ion Limited and existing lenders could potentially restructure this debt, contingent on a successful equity raise and regulatory approvals. The proposed arrangement aims to extend loan maturities and convert some debt into equity, which could improve EQTEC’s financial stability and support its strategic de-leveraging efforts.
The most recent analyst rating on (GB:EQT) stock is a Hold with a £0.50 price target. To see the full list of analyst forecasts on EQTEC plc stock, see the GB:EQT Stock Forecast page.
EQTEC plc announced the conversion of a £50,000 principal amount into 30,595,875 new ordinary shares as part of its facility with Global Investment Strategy UK Limited. The new shares will be admitted to trading on AIM, increasing the total number of ordinary shares to 678,892,432. This move is part of EQTEC’s strategic financial activities, potentially impacting shareholder interests and enhancing the company’s market presence.
The most recent analyst rating on (GB:EQT) stock is a Hold with a £0.50 price target. To see the full list of analyst forecasts on EQTEC plc stock, see the GB:EQT Stock Forecast page.
EQTEC plc has announced significant leadership changes and cost optimization measures, including the suspension of the Rebel Ion Option Agreement and the introduction of a new funding facility. The company is undergoing a strategic realignment to enhance capital efficiency and execution maturity, with a focus on reducing costs, stabilizing operations in key regions, and expanding revenue. The new funding facility aims to support working capital and advance EQTEC’s entry into the synthetic fuels sector, aligning with its growth strategy.
The most recent analyst rating on (GB:EQT) stock is a Hold with a £0.50 price target. To see the full list of analyst forecasts on EQTEC plc stock, see the GB:EQT Stock Forecast page.